Page 538 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

516 PART IV Specific Malignancies in the Small Animal Patient

64. Holt DE, Goldschmidt MH: Nasal in dogs: five cases (2005-2011), 86. Avner A, Dobson JM, Sales JI, et al.: Retrospective review of 50
J Small Anim Pract 52:660–663, 2011. canine nasal tumours evaluated by low-field magnetic resonance
65. Gamblin FM, Sagartz JE, Couto CG: Overexpression of p53 tumor imaging, J Small Anim Pract 49:233–239, 2008.
VetBooks.ir suppressor protein in spontaneously arising neoplasms of dogs, Am 87. Agthe P, Caine AR, Gear RNA, et al.: Prognostic significance
of specific magnetic resonance imaging features in canine nasal
J Vet Res 58:857–863, 1997.
66. Kleiter MK, Malarkey DE, Ruslander DE, et al.: Expression of
2009.
cyclooxygenase-2 in canine epithelial nasal tumors, Vet Radiol tumours treated by radiotherapy, J Small Anim Pract 50:641–648,
Ultrasound 45:255–260, 2004. 88. Petite AFB, Dennis R: Comparison of radiography and magnetic
67. Borzacchiello G, Paciello O, Papparella S: Expression of cyclooxy- resonance imaging for evaluating the extent of nasal neoplasia in
genase-1 and -2 in canine nasal carcinomas, J Comp Pathol 131:70– dogs, J Small Anim Pract 47:529–536, 2006.
76, 2004. 89. Burk RL: Computed tomographic imaging of nasal disease in 100
68. Impellizeri JA, Esplin DG: Expression of cyclooxygenase-2 in dogs, Vet Radiol Ultrasound 33:177–180, 1992.
canine nasal carcinomas, Vet J 176:408–410, 2008. 90. Lux CN, Culp WT, Johnson LR, et al.: Prospective comparison of
69. Belshaw Z, Constantio-Casas F, Brearley MJ, et al.: COX-2 expres- tumor staging using computed tomography versus magnetic reso-
sion and outcome in canine nasal carcinomas treated with hypo- nance imaging findings in dogs with nasal neoplasia: a pilot study,
fractionated radiotherapy, Vet Comp Oncol 9:141–148, 2010. Vet Radiol Ultrasound 58:315–325, 2017.
70. Shiomitsu K, Johnson CL, Malarkey DE, et al.: Expression of epi- 91. Gibbs C, Lane JG, Denny HR: Radiological features of intra-
dermal growth factor receptor and vascular endothelial growth fac- nasal lesions in the dog: a review of 100 cases, J Small Anim Pract
tor in malignant canine epithelial nasal tumours, Vet Comp Oncol 20:515–535, 1979.
7:106–114, 2009. 92. Russo M, Lamb CR, Jakovljevic S: Distinguishing rhinitis and
71. Gramer I, Killick D, Scase T, et al.: Expression of VEGFR and nasal neoplasia by radiography, Vet Radiol Ultrasound 41:118–124,
PDGFR-α/-β in 187 canine nasal carcinomas, Vet Comp Oncol 2000.
15:1041–1050, 2017. 93. Bowen SR, Chappell RJ, Bentzen SM, et al.: Spatially resolved
72. Paciello O, Borzacchiello G, Varricchio E, et al.: Expression of regression analysis of pre-treatment FDG, FLT and Cu-ATSM
peroxisome proliferator-activated receptor gamma (PPAR-γ) in PET from post-treatment FDG PET: an exploratory study, Radio-
canine nasal carcinomas, J Vet Med A Physiol Pathol Clin Med 54: ther Oncol 105:41–48, 2012.
406–410, 2007. 94. Bradshaw TJ, Bowen SR, Jallow N, et al.: Heterogeneity in intra-
61
18
18
73. Vanherberghen M, Day MJ, Delvaux F, et al.: An Immunohisto- tumor correlations of F-FDG, F-FLT, and Cu-ATSM PET in
chemical study of the inflammatory infiltrate associated with nasal canine sinonasal tumors, J Nucl Med 54:1931–1937, 2013.
carcinoma in dogs and cats, J Comp Pathol 141:17–26, 2009. 95. Bradshaw TJ, Yip S, Jallow N, et al.: Spatiotemporal stability of
74. Rassnick KM, Goldkamp CE, Erb HN, et al.: Evaluation of Cu-ATSM and FLT positron emission tomography distributions
factors associated with survival in dogs with untreated nasal during radiation therapy, Int J Radiation Oncol Biol Phys 89:399–
carcinomas: 139 cases (1993-2003), J Am Vet Med Assoc 229: 405, 2014.
401–406, 2006. 96. Bradshaw TK, Bowen SR, Deveau MA, et al.: Molecular imaging
75. Saunders JH, Van Bree H, Gielen I, et al.: Diagnostic value of com- biomarkers of resistance to radiation therapy for spontaneous nasal
puted tomography in dogs with chronic nasal disease, Vet Radiol tumors in canines, Int J Radiation Oncol Biol Phys 91:787–795,
Ultrasound 44:409–413, 2003. 2015.
76. Burrow RD: A nasal dermoid sinus in an English bull terrier, 97. Bradshaw T, Fu R, Bowen S, et al.: Predicting location of recur-
J Small Anim Pract 45:572–574, 2004. rence using FDG, FLT and Cu-ATSM PET in canine sinonasal
77. Beck JA, Hunt GB, Goldsmid SE, et al.: Nasopharyngeal obstruc- tumors treated with radiotherapy, Phys Med Biol 60:5211–5224,
tion due to cystic Rathke’s clefts in two dogs, Aust Vet J 77:94–96, 2015.
1999. 98. Withrow SJ, Susaneck SJ, Macy DW, et al.: Aspiration and punch
78. Lobetti RG: A retrospective study of chronic nasal disease in 75 biopsy techniques for nasal tumors, J Am Anim Hosp Assoc 21:551–
dogs, J S Afr Vet Assoc 80:224–228, 2009. 554, 1985.
79. Strasser JL, Hawkins EC: Clinical features of epistaxis in dogs: a 99. Rudd RG, Richardson DC: A diagnostic and therapeutic approach to
retrospective study of 35 cases (1999-2002), J Am Anim Hosp Assoc nasal disease in dogs, Compend Contin Educ Pract Vet 7:103–112, 1985.
41:179–184, 2005. 100. Kuhlman GM, Taylor AR, Thieman-Mankin KM, et al.: Use of a
80. Plickert HD, Tichy A, Hirt RA: Characteristics of canine nasal dis- frameless computed tomography guided stereotactic biopsy system
charge related to intranasal diseases: a retrospective study of 105 for nasal biopsy in five dogs, J Am Vet Med Assoc 248:929–934,
cases, J Sm Anim Prac 55:145–152, 2014. 2016.
81. Smith MO, Turrel JM, Bailey CS, et al.: Neurologic abnormalities 101. Lent SEF, Hawkins EC: Evaluation of rhinoscopy and rhinoscopy-
as the predominant signs of neoplasia of the nasal cavity in dogs assisted mucosal biopsy in diagnosis of nasal disease in dogs: 199
and cats: seven cases (1973-1986), J Am Vet Med Assoc 195:242– cases (1985-1989), J Am Vet Med Assoc 201:1425–1429, 1992.
245, 1989. 102. Harris BJ, Lourenco BN, Dobson JM, et al.: Diagnostic accuracy
82. Thrall DE, Robertson ID, McLeod DA, et al.: A comparison of of three biopsy techniques in 117 dogs with intra-nasal neoplasia,
radiographic and computed tomographic findings in 31 dogs with J Sm Anim Prac 55:219–224, 2014.
malignant nasal cavity tumors, Vet Radiol 30:59–66, 1989. 103. Clercx C, Wallon J, Gilbert S, et al.: Imprint and brush cytology
83. Park RD, Beck ER, LeCouteur RA: Comparison of computed in the diagnosis of canine intranasal tumours, J Small Anim Pract
tomography and radiography for detecting changes induced by 37:423–427, 1996.
malignant nasal neoplasia in dogs, J Am Vet Med Assoc 201:1720– 104. Theon AP, Madewell BR, Harb MF, et al.: Megavoltage irradiation
1724, 1992. of neoplasms of the nasal and paranasal cavities in 77 dogs, J Am Vet
84. Codner EC, Lurus AG, Miller JB, et al.: Comparison of com- Med Assoc 202:1469–1475, 1993.
puted tomography with radiography as a noninvasive diagnostic 105. Adams WM, Miller PE, Vail DM, et al.: An accelerated tech-
technique for chronic nasal disease in dogs, J Am Vet Med Assoc nique for irradiation of malignant canine nasal and paranasal sinus
202:1106–1110, 1993. tumors, Vet Radiol Ultrasound 39:475–481, 1998.
85. Drees R, Forrest LJ, Chappell R: Comparison of computed 106. Adams WM, Kleiter MM, Thrall DE, et al.: Prognostic significance
tomography and magnetic resonance imaging for the evalu- of tumor histology and computed tomographic staging for radia-
ation of canine intranasal neoplasia, J Small Anim Pract 50: tion treatment response of canine nasal tumors, Vet Radiol Ultra-
334–340, 2009. sound 50:330–335, 2009.